Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling

被引:117
作者
Villarreal, FJ [1 ]
Griffin, M [1 ]
Omens, J [1 ]
Dillmann, W [1 ]
Nguyen, J [1 ]
Covell, J [1 ]
机构
[1] Univ Calif San Diego, Med Ctr, Dept Med, San Diego, CA 92103 USA
关键词
infarction; remodeling; collagen; metalloproteinases;
D O I
10.1161/01.CIR.0000089090.05757.34
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Myocardial infarction (MI) is associated with early metalloproteinase (MMP) activation and extracellular matrix (ECM) degradation. We hypothesized that preserving the original ECM of the infarcted left ventricle (LV) by use of early short-term doxycycline (DOX) treatment preserves cardiac structure and function. Methods and Results-LV morphometry and function were measured in 3 groups of rats ( sham, MI, and MI + DOX). DOX (30 mg/kg per day) was given orally 48 hours before and 48 hours after MI. Rats were examined at 2 and 4 weeks after MI. By 4 weeks, DOX significantly decreased (P<0.05 versus MI) the heart weight to body weight ratio, myocyte cross-sectional area, and internal LV diameter, whereas it preserved anterior wall thickness within the infarct. Collagen/muscle area fraction did not change in the region of the infarct/scar. Parallel left shifts (versus MI) were observed in pressure-volume relationships of DOX MI rats at all pressures. DOX treatment also shifted passive epicardial strains within the scar area toward normal values. No differences were observed in LV end-diastolic or peak systolic pressures, peak positive or negative LV dP/dt, or isovolumic relaxation rates. Assessment of LV global MMP and MMP-2/9 activities 1 hour after MI using fluorescent probes yielded significant differences with DOX. Conclusions-Brief, early MMP inhibition after MI yields preservation of LV structure and global as well as scar area passive function, supporting the concept that preserving the original ECM early after coronary occlusion lessens ventricular remodeling.
引用
收藏
页码:1487 / 1492
页数:6
相关论文
共 28 条
  • [1] Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: Report of a prospective (Phase II) multicenter study
    Baxter, BT
    Pearce, WH
    Waltke, EA
    Littooy, FN
    Hallett, JW
    Kent, KC
    Upchurch, GR
    Chaikof, EL
    Mills, JL
    Fleckten, B
    Longo, GM
    Lee, JK
    Thompson, RW
    [J]. JOURNAL OF VASCULAR SURGERY, 2002, 36 (01) : 1 - 12
  • [2] CAULFIELD JB, 1979, LAB INVEST, V40, P364
  • [3] Matrix metalloproteinase inhibition after myocardial infarction - A new approach to prevent heart failure?
    Creemers, EEJM
    Cleutjens, JPM
    Smits, JFM
    Daemen, MJAP
    [J]. CIRCULATION RESEARCH, 2001, 89 (03) : 201 - 210
  • [4] Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms
    Curci, JA
    Mao, DL
    Bohner, DG
    Allen, BT
    Rubin, BG
    Reilly, JM
    Sicard, GA
    Thompson, RW
    [J]. JOURNAL OF VASCULAR SURGERY, 2000, 31 (02) : 325 - 341
  • [5] Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs
    Etoh, T
    Joffs, C
    Deschamps, AM
    Davis, J
    Dowdy, K
    Hendrick, J
    Baicu, S
    Mukherjee, R
    Manhaini, M
    Spinale, FG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (03): : H987 - H994
  • [6] FRANTZ S, 2000, CIRCULATION, V102, P357
  • [7] Golub L M, 1998, Adv Dent Res, V12, P12
  • [8] Inhibition of proteolytic, serpinolytic, and progelatinase-B activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives
    Grenier, D
    Plamondon, P
    Sorsa, T
    Lee, HM
    McNamara, T
    Ramamurthy, NS
    Golub, LM
    Teronen, O
    Mayrand, D
    [J]. JOURNAL OF PERIODONTOLOGY, 2002, 73 (01) : 79 - 85
  • [9] Clinical potential of matrix metalloprotease inhibitors in cancer therapy
    Heath, EI
    Grochow, LB
    [J]. DRUGS, 2000, 59 (05) : 1043 - 1055
  • [10] Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
    Heymans, S
    Luttun, A
    Nuyens, D
    Theilmeier, G
    Creemers, E
    Moons, L
    Dyspersin, GD
    Cleutjens, JPM
    Shipley, M
    Angellilo, A
    Levi, M
    Nübe, O
    Baker, A
    Keshet, E
    Lupu, F
    Herbert, JM
    Smits, JFM
    Shapiro, SD
    Baes, M
    Borgers, M
    Collen, D
    Daemen, MJAP
    Carmeliet, P
    [J]. NATURE MEDICINE, 1999, 5 (10) : 1135 - 1142